Basin used to supply a good chart off his Bloomberg. With my calculations I just assume all will be exercised at some later date in time. I have reasons why the stock is expensive here or extremely cheap. So I just wait for the results. The structure developed around the company and taking into account a platform for all solid tumors makes it very cheap. Time will tell.